Clinical Pharmacology and Nursing

by Baer, Charold Lee Morris; Williams, Bradley R.

• ISBN13: 9780874347722
• ISBN10: 0874347726
• Edition: 3rd
• Format: Hardcover
• Copyright: 1996-02-01
• Publisher: Springhouse Pub Co

Summary

Includes software offering more than 1,300 multiple-choice questions and other activities complete with answers and rationales, nursing process step, client need category, taxonomic level when applicable, chapter and unit tests, a comprehensive test, and a score report. Text has been updated to include all approved drugs. Contents include general pharmacology, the nursing process and pharmacotherapeutics, coverage of all drug classes, and data on hundreds of generic drugs. Charts, diagrams, and illustrations.

Table of Contents

ADVISORY BOARD	xiii	(1)
CONSULTANTS	xiv	(1)
CONTRIBUTORS	xv	(2)
FOREWORD	xvii	(2)
PREFACE	xix
UNIT ONE: GENERAL PHARMACOLOGY	1	(68)
UNIT INTRODUCTION	1	(2)
Charold L. Baer, RN, PhD, FCCM, CCRN
1. INTRODUCTION TO PHARMACOLOGY	3	(16)
Janet M. Farahmand, CRN, MSN. EdD
2. PHARMACOKINETICS	19	(19)
James D. Carlson, PharmD, RPh
Phyllis G. Hummel, RN, MSN
3. PHARMACODYNAMICS	38	(12)
James D. Carlson, PharmdD, RPH;
Phyllis G. Hummel, RN, MSN
4. PHARMACOTHERAPEUTICS	50	(13)
Carol L. Beck, PharmD, RPh, PhD
Phyllis G. Hummel, RN, MSN
5. ADVERSE DRUG REACTIONS	63	(16)
Ann Ziegler Sedore, RN, PhD
UNIT TWO: THE NURSING PROCESS AND DRUG ADMINISTRATION	69	(113)
UNIT INTRODUCION	69	(3)
Brenda L. Lyon, RN, DNS, FAAN
Patricia A. Diehl, RN, BSN, MA
6. THE NURSING PROCESS AND DRUG THERAPY	72	(18)
Meredith Ann McCord, RN, MS
Rebecca E. Boehne, RN, PhD
7. RESPONSIBILITIES IN DRUG ADMINISTRATION	90	(15)
Patricia A. Diehl, RN, BSN, MA
8. DOSAGE MEASUREMENTS AND CALCULATIONS	105	(17)
Catherine M. Todd, RN, C, EdD
Belle Erickson, RN, C, PhD
9. ROUTES AND TECHNIQUES OF ADMINISTRATION	122	(27)
Rebecca E. Boehne, RN, PhD
10. THE PEDIATRIC PATIENT	149	(14)
Kathleen C. Byington, RN, MSN
11. THE GERIATRIC PATIENT	163	(10)
Brenda M. Splitz Schlesinger, RN, MSN, GNP, CDE
12. THE PREGNANT OR BREAST-FEEDING PATIENT	173	(9)
Linda P. Brown, RN, PhD, FAAN
UNIT THREE: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM	182	(80)
UNIT INTRODUCTION	182	(6)
Margaret I. Wallhagen, RN, PhD
13. CHOLINERGIC AGENTS	188	(13)
Naomi R. Ballard, RN, MA, MS, CNRN
14. CHOLINERGIC BLOCKING AGENTS	201	(10)
Naomi R. Ballard, RN, MA, MS, CNRN
15. ADRENERGIC AGENTS	211	(21)
William A. Kehoe, PharmD, BCPS
16. ADRENERGIC BLOCKING AGENTS	232	(20)
William A. Kehoe, PharmD, BCPS
17. NEUROMUSCULAR BLOCKING AGENTS	252	(10)
Naomi R. Ballard, RN, MA, MS, CNRN
UNIT FOUR: DURGS TO TREAT NEUROLOGIC AND NEUROMUSCULAR SYSTEM DISORDERS	262	(59)
UNIT INTRODUCTION	262	(4)
Jan L. Lee, RN, CS, PhD
18. SKELETAL MUSCLE RELAXING AGENTS	266	(13)
Lilliam Sklaver, PharmD
19. ANTIPARKINSONIAN AGENTS	279	(14)
Martin R. Giannamore, PharmD, RPh
20. ANTICONVULSANT AGENTS	293	(28)
Jan L. Lee, RN, CS, PhD
UNIT FIVE: DRUGS TO PREVENT AND TREAT PAIN	321	(75)
UNIT INTRODUCTION	321	(4)
Joseph F. Steiner, PharmD, RPh
21. NONNARCOTIC ANALGESIC, ANTIPYRETIC, AND NONSTEROIDAL ANTI-INFLAMMATORY AGENTS	325	(21)
Barbara L. MacDermott, RN, MS
22. NARCOTIC AGONIST AND ANTAGONIST AGENTS	346	(20)
Barbara L. MacDermott, RN, MS
23. GENERAL ANESTHETIC AGENTS	366	(15)
John Nagelhout, RN, PhD, CRNA
24. LOCAL AND TOPICAL ANESTHETIC AGENTS	381	(15)
N. Michael Davis, MS, RPh
UNIT SIX: DRUGS TO ALTER PSYCHOGENIC BEHAVIOR AND PROMOTE SLEEP	396	(69)
UNIT INTRODUCTION	396	(2)
Barbara Gross Braverman, RN, CS, MSN
25. SEDATIVE AND HYPNOTIC AGENTS	398	(21)
Patricia O'Leary, RN, DSN
26. ANTIDEPRESSANT AND ANTIMANIC AGENTS	419	(19)
David Pipher, PharmD, RPh
27. ANTIANXIETY AGENTS	438	(12)
David Pipher, PharmD, RPh
28. ANTIPSYCHOTIC AGENTS	450	(15)
Vivian Hayes Churness, RN, DNSc
UNIT SEVEN: DRUGS TO IMPROVE CARDIOVASCULAR FUNCTION	465	(135)
UNIT INTRODUCTION	465	(4)
Rita Short Monahan, RN, CS, MSN, EdD
29. CARDIAC GLYCOSIDE AGENTS AND BIPYRIDINES	469	(14)
Robin Donohoe Dennison, RN, CS, MSN, CCRN
Jean Nappi, PharmD
30. ANTIARRHYTMIC AGENTS	483	(32)
Richard K. Gibson, RN, MN, JD, CCRN, CS
Douglas R. Geraets, PharmD, RPh
31. ANTIANGINAL AGENTS	515	(18)
Richard K. Gibson, RN, MN, JD, CCRN, CS
32. ANTIHYPERTENSIVE AGENTS	533	(28)
Barbara Given, RN, PhD, FAAN
Douglas R. Geraets, PharmD, RPh
33. DIURETIC AGENTS	561	(22)
Kathleen Whittaker Groves, RN, MS
34. ANTILIPEMIC AGENTS	583	(17)
Douglas R. Geraets, PharmD, RPh
UNIT EIGHT: DRUGS AFFECTING THE HEMATOLOGIC SYSTEM	600	(51)
UNIT INTRODUCTION	600	(9)
C. Lynne Ostrow, RN, EdD
35. HEMATINIC AGENTS	609	(15)
C. Lynne Ostrow, RN, EdD
36. ANTICOAGULANT AGENTS	624	(19)
C. Lynne Ostrow, RN, EdD
37. THROMBOLYTIC AGENTS	643	(8)
C. Lynne Ostrow, RN, EdD
UNIT NINE: DRUGS TO IMPROVE RESPIRATORY FUNCTION	651	(46)
UNIT INTRODUCTION	651	(5)
Susan B. Stillwell, RN, MSN, CCRN
38. METHYLXANTHINE AGENTS	656	(13)
Gary D. Smith, PharmD, RPh
Gary Milavetz, PharmD, RPh
39. EXPECTORANT, ANTITUSSIVE, AND MUCOLYTIC AGENTS	669	(16)
Susam B. Stillwell, RN, MSN, CCRN
40. DECONGESTANT AGENTS	685	(12)
Colleen M. Lucas, RN, CS, MN
UNIT TEN: DRUGS TO IMPROVE GASTROINTESTINAL FUNCTION	697	(74)
UNIT INTRODUCION	697	(2)
Frances W. Quinless, RN, PhD
41. ADSORBENT, ANTIFLATULENT, AND DIGESTIVE AGENTS	699	(11)
Frances W. Quinless, RN, PhD
42. ANTIDIARRHEAL AND LAXATIVE AGENTS	710	(24)
Frances W. Quinless, RN, PhD
43. EMETIC AND ANTIEMETIC AGENTS	734	(19)
Joseph Steiner, PharmD, RPh
44. PEPTIC ULCER AGENTS	753	(18)
Joseph Steiner, PharmD, RPh
UNIT ELEVEN: DRUGS FOR FLUID, ELECTROLYTE, AND NUTRITIONAL BALANCE	771	(62)
UNIT INTRODUCTION	771	(4)
Patricia Peschman, RN, MS, CNN
Dean E. Goldberg, PharmD
45. VITAMIN, MINERAL, AND OTHER NUTRITIONAL AGENTS	775	(24)
Patricia Peschman, RN, MS, CNN
Dean E. Goldberg, PharmD
46. ELECTROLYTE REPLACEMENT AGENTS	799	(11)
Carmel A. Esposito, RN, MSN, EdD
47. ALKALINIZING AND ACIDIFYING AGENTS	810	(12)
Bruce C. Carlstedt, PharmD, RPh
48. CATION-EXCHANGE RESIN AND AMMONIA-DETOXICATING AGENTS	822	(11)
Patricia Peschman, RN, MS, CNN
Dean E. Goldberg, PharmD
UNIT TWELVE: DRUGS TO TREAT ENDOCRINE SYSTEM DISORDERS	833	(105)
UNIT INTRODUCTION	833	(4)
David W. Hawkins, PharmD
49. HYPOGLYCEMIC AGENTS AND GLUCAGON	837	(19)
Rita Short Monahan, RN, CS, MSN, EdD
50. THYROID AND ANTITHYROID AGENTS	856	(16)
Sande Jones, RN, C, MSN, MSEd
51. PARATHYROID AGENTS	872	(11)
Margot T. Stock, RN, MSN, DPhil (Oxon)
52. PITUITARY AGENTS	883	(14)
Margot T. Stock, RN, MSN, DPhil (Oxon)
53. ANDROGENIC AND ANABOLIC STEROID AGENTS	897	(8)
James D. Carlson, PharmD, RPh
Phyllis G. Hummel, RN, MSN
54. ESTROGENS, PROGESTINS, AND ORAL CONTRACEPTIVE AGENTS	905	(22)
Kathleen A. Johnson, PharmD, MPH, PhD
Kathleen Hill-Besinque, PharmD, MSEd
55. UTERINE MOTILITY AGENTS	927	(11)
Keith M. Olsen, PharmD
Laura D'Oria PharmD, RPh
UNIT THIRTEEN: DRUGS TO CONTROL INFLAMMATION, ALLERGY, AND ORGAN REJECTION	938	(59)
UNIT INTRODUCTION	938	(4)
Eileen Hayes Lantier, RN, MSN
56. ANTHISTAMINIC AGENTS	942	(13)
Colleen M. Lucas, RN, CS, MN
57. CORTICOSTEROID AND OTHER IMMUNOSUPPRESSANT AGENTS	955	(26)
Lynne Kreutzer-Baraglia, RN, MS
Beverly A. Post, RN, MS
58. URICOSURICS, OTHER ANTIGOUT AGENTS, AND GOLD SALTS	981	(16)
Karna J. Bramble, RN, MS, CGNP, PhD
UNIT FOURTEEN: DRUGS TO PREVENT OR TREAT INFECTION	997	(140)
UNIT INTRODUCTION	997	(4)
Mary Y. Ma, PharmD
59. ANTIBACTERIAL AGENTS	1001	(49)
Mary Y. Ma, PharmD
60. ANTITUBERCULAR AND ANTILEPROTIC AGENTS	1050	(11)
Larry A. Pfeifer, BSPh, RPh
61. ANTIVIRAL AGENTS	1061	(18)
Paul J. Vitale, PharmD, FASCP
62. ANTIMYCOTIC (ANTIFUNGAL) AGENTS	1079	(18)
Paul J. Vitale, PharmD, FASCP
63. ANTHELMINTIC AGENTS	1097	(11)
Bradford G. Wallenberg, PharmD, RPh
64. ANTIMALARIAL AND OTHER ANTIPROTOZOAL AGENTS	1108	(17)
Bridget A. Haupt, PharmD
65. URINARY ANTISEPTIC AGENTS	1125	(12)
Mary Y. Ma, PharmD
UNIT FIFTEEN: DRUGS TO TREAT MALIGNANT NEOPLASMS	1137	(97)
UNIT INTRODUCTION	1137	(6)
Brenda M. Nevidjon, RN, MSN;
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
66. ALKYLATING AGENTS	1143	(22)
Brenda M. Nevidjon, RN, MSN
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
67. ANTIMETABOLITE AGENTS	1165	(15)
Brenda M. Nevidjon, RN, MSN
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
68. ANTIBIOTIC ANTINEOPLASTIC AGENTS	1180	(9)
Brenda M. Nevidjon, RN, MSN
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
69. HORMONAL ANTINEOPLASTIC AGENTS	1189	(21)
Brenda M. Nevidjon, RN, MSN
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
70. OTHER ANTINEOPLASTIC AGENTS	1210	(24)
Brenda M. Nevidjon, RN, MSN
Teresa L. Coluccio, RN, MN, OCN
Lisa J. Woodard, BPharm, MPH, RPh
UNIT SIXTEEN: OTHER MAJOR DRUGS	1234	(62)
UNIT INTRODUCTION	1234	(2)
Steven R. Abel, PharmD, RPh
71. OPHTHALMIC AGENTS	1236	(23)
Sara Lynn Machowsky, RN, MS
72. OTIC AGENTS	1259	(11)
Nina Hubej Olesinski, RN, MSN, PhD
73. UNCATEGORIZED AND OTHER AGENTS	1270	(26)
Bridget A. Haupt, PharmD
Marlene Ciranowicz, RN, MSN, CDE
APPENDICES AND INDEX
1. ANSWERS TO STUDY QUESTIONS	1296	(7)
2. COMMONLY USED ABBREVIATIONS IN DRUG THERAPY	1303	(2)
3. NANDA TAXONOMY OF NURSING DIAGNOSES	1305	(2)
4. INTEGUMENTARY SYSTEM AGENTS	1307	(9)
Marcia J. Hill, RN, MSN
5. ACTIVE AND PASSIVE IMMUNITY AGENTS	1316	(4)
Kathleen C. Byington, RN, MSN
6. SUBSTANCE ABUSE	1320	(3)
Anne Myers Gudmundsen, RN, PhD
INDEX	1323	(62)
ABOUT THE STUDENT REVIEW DISK	1385
THE STUDENT REVIEW DISK